Back to search

Uk Biopharma Ltd

08148167

active
Private Limited Company
england wales
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Current liabilities exceed current assets (-10)

Details

L3K ROMA PARVA, WOLVERHAMPTON, WV1 4NB
Incorporated 18/07/2012

Compliance

Last accounts

31/07/2025

micro entity

Next accounts due

30/04/2027

On track

Confirmation statement

Last: 18/07/2025

Due 01/08/2026

On track

Industry

21100
Manufacture of basic pharmaceutical products
46460
Wholesale of pharmaceutical goods
86210
General medical practice activities
86900
Other human health activities

Officers

Dr Gayane Chobanyan

director · Since 18/07/2012

DOCTOR

BRITISH · ENGLAND · Age 61

Persons with Significant Control

Dr Gayane Chobanyan

75–100% shares
75–100% votes
Appoint directors

British · England · Age 61

738, Stafford Road, Wolverhampton, WV10 6NR

Notified 06/04/2016

CompanyRankvs 290+ SIC 21100 peers
57

Financial strength72th percentile among SIC peers · 18/25
Employees50th percentile among SIC peers · 8/15
LiquidityCurrent ratio 0.05× · 2/20
Longevity14 years trading (max 15) · 14/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength18/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees8/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity14/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/07/2025

Net Worth

£39k

Balance sheet strength

Cash

Cash in the bank

Net Current Assets

£40k

Working capital

Current Assets

£2k

Current Liabilities

£42k

Fixed Assets

£104

1avg. employees

Balance Sheet

Assets less current liabilities£39k
Prepared with Companies House

EstimatesDerived

YearCurrent RatioImplied Profit
20250.05-£813
20240.04-£5k
20230.02-£2k
20220.13-£1k
20210.01+£4k
20200.10+£14k
20190.45-£2k
20180.00

Derived from filed accounts. Not audited figures.